Bioxyne Ltd
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Onlin… Read more
Bioxyne Ltd (BXN) - Net Assets
Latest net assets as of December 2025: AU$20.17 Million AUD
Based on the latest financial reports, Bioxyne Ltd (BXN) has net assets worth AU$20.17 Million AUD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$34.63 Million) and total liabilities (AU$14.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$20.17 Million |
| % of Total Assets | 58.26% |
| Annual Growth Rate | -0.35% |
| 5-Year Change | 488.27% |
| 10-Year Change | 633.34% |
| Growth Volatility | 975.9 |
Bioxyne Ltd - Net Assets Trend (2000–2025)
This chart illustrates how Bioxyne Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bioxyne Ltd (2000–2025)
The table below shows the annual net assets of Bioxyne Ltd from 2000 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$11.38 Million | +244.77% |
| 2024-06-30 | AU$3.30 Million | -78.01% |
| 2023-06-30 | AU$15.01 Million | +4213.03% |
| 2022-06-30 | AU$-364.84K | -118.87% |
| 2021-06-30 | AU$1.93 Million | -25.89% |
| 2020-06-30 | AU$2.61 Million | -16.96% |
| 2019-06-30 | AU$3.14 Million | -27.29% |
| 2018-06-30 | AU$4.32 Million | +4.62% |
| 2017-06-30 | AU$4.13 Million | +166.28% |
| 2016-06-30 | AU$1.55 Million | +20.85% |
| 2015-06-30 | AU$1.28 Million | +19.75% |
| 2014-06-30 | AU$1.07 Million | +608.67% |
| 2013-06-30 | AU$-210.73K | -103.58% |
| 2012-06-30 | AU$5.89 Million | +4635.19% |
| 2011-06-30 | AU$124.34K | +0.85% |
| 2010-06-30 | AU$123.29K | +185.76% |
| 2009-06-30 | AU$43.15K | +106.92% |
| 2008-06-30 | AU$-623.12K | -384.99% |
| 2007-06-30 | AU$218.65K | -46.75% |
| 2006-06-30 | AU$410.58K | +119.59% |
| 2005-06-30 | AU$186.98K | -84.09% |
| 2004-06-30 | AU$1.18 Million | +21.44% |
| 2003-06-30 | AU$967.78K | -77.27% |
| 2002-06-30 | AU$4.26 Million | -52.82% |
| 2001-06-30 | AU$9.02 Million | -27.41% |
| 2000-06-30 | AU$12.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bioxyne Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 927615900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$21.48 Million | 183.83% |
| Other Comprehensive Income | AU$908.64K | 7.78% |
| Total Equity | AU$11.68 Million | 100.00% |
Bioxyne Ltd Competitors by Market Cap
The table below lists competitors of Bioxyne Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Milae Bioresources Co. Ltd
KQ:218150
|
$20.44 Million |
|
OHTL Public Company Limited
BK:OHTL
|
$20.45 Million |
|
Ann Joo Resources Bhd
KLSE:6556
|
$20.45 Million |
|
SSC Security Services Corp
OTCQX:SECUF
|
$20.45 Million |
|
Elliptic Laboratories AS
OL:ELABS
|
$20.44 Million |
|
Matrimony.Com Limited
NSE:MATRIMONY
|
$20.44 Million |
|
Thachang Green Energy PCL
BK:TGE
|
$20.43 Million |
|
Source Rock Royalties Ltd
V:SRR
|
$20.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bioxyne Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,606,224 to 11,682,691, a change of 8,076,467 (224.0%).
- Net income of 4,901,181 contributed positively to equity growth.
- Share repurchases of 2,453,030 reduced equity.
- Other comprehensive income increased equity by 696,421.
- Other factors increased equity by 4,931,895.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$4.90 Million | +41.95% |
| Share Repurchases | AU$2.45 Million | -21.0% |
| Other Comprehensive Income | AU$696.42K | +5.96% |
| Other Changes | AU$4.93 Million | +42.22% |
| Total Change | AU$- | 223.96% |
Book Value vs Market Value Analysis
This analysis compares Bioxyne Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.83x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.02x to 8.83x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-06-30 | AU$2.97 | AU$0.05 | x |
| 2001-06-30 | AU$2.47 | AU$0.05 | x |
| 2002-06-30 | AU$1.01 | AU$0.05 | x |
| 2003-06-30 | AU$0.23 | AU$0.05 | x |
| 2004-06-30 | AU$0.22 | AU$0.05 | x |
| 2005-06-30 | AU$0.03 | AU$0.05 | x |
| 2006-06-30 | AU$0.04 | AU$0.05 | x |
| 2007-06-30 | AU$0.02 | AU$0.05 | x |
| 2008-06-30 | AU$-0.05 | AU$0.05 | x |
| 2009-06-30 | AU$0.00 | AU$0.05 | x |
| 2010-06-30 | AU$0.01 | AU$0.05 | x |
| 2011-06-30 | AU$0.01 | AU$0.05 | x |
| 2012-06-30 | AU$0.03 | AU$0.05 | x |
| 2013-06-30 | AU$0.00 | AU$0.05 | x |
| 2014-06-30 | AU$0.01 | AU$0.05 | x |
| 2015-06-30 | AU$0.01 | AU$0.05 | x |
| 2016-06-30 | AU$0.01 | AU$0.05 | x |
| 2017-06-30 | AU$0.02 | AU$0.05 | x |
| 2018-06-30 | AU$0.01 | AU$0.05 | x |
| 2019-06-30 | AU$0.00 | AU$0.05 | x |
| 2020-06-30 | AU$0.00 | AU$0.05 | x |
| 2021-06-30 | AU$0.00 | AU$0.05 | x |
| 2022-06-30 | AU$0.00 | AU$0.05 | x |
| 2023-06-30 | AU$0.01 | AU$0.05 | x |
| 2024-06-30 | AU$0.00 | AU$0.05 | x |
| 2025-06-30 | AU$0.01 | AU$0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bioxyne Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 41.95%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.11%
- • Asset Turnover: 1.46x
- • Equity Multiplier: 1.79x
- Recent ROE (41.95%) is above the historical average (-199.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -11.47% | -15847.32% | 0.00x | 1.01x | AU$-2.67 Million |
| 2001 | -34.44% | -944.68% | 0.03x | 1.06x | AU$-4.01 Million |
| 2002 | -112.83% | -1837.29% | 0.05x | 1.15x | AU$-5.23 Million |
| 2003 | -527.39% | -290.99% | 0.89x | 2.05x | AU$-5.20 Million |
| 2004 | -369.02% | -397.53% | 0.46x | 2.02x | AU$-4.45 Million |
| 2005 | -2103.51% | -283.20% | 1.07x | 6.96x | AU$-3.95 Million |
| 2006 | -457.39% | -111.48% | 1.57x | 2.61x | AU$-1.92 Million |
| 2007 | -789.42% | -206.19% | 1.37x | 2.79x | AU$-1.75 Million |
| 2008 | 0.00% | -197.33% | 1.40x | 0.00x | AU$-1.27 Million |
| 2009 | -488.83% | -18.38% | 2.36x | 11.26x | AU$-215.22K |
| 2010 | 65.00% | 10.66% | 2.52x | 2.42x | AU$67.82K |
| 2011 | 0.85% | 0.11% | 4.26x | 1.78x | AU$-11.38K |
| 2012 | -30.30% | -1447.28% | 0.02x | 1.17x | AU$-2.37 Million |
| 2013 | 0.00% | -703.14% | 1.25x | 0.00x | AU$-6.17 Million |
| 2014 | 111.09% | 49.79% | 1.60x | 1.40x | AU$1.08 Million |
| 2015 | 15.66% | 12.22% | 1.09x | 1.18x | AU$72.67K |
| 2016 | 14.43% | 11.06% | 1.01x | 1.30x | AU$68.72K |
| 2017 | -18.54% | -37.28% | 0.43x | 1.15x | AU$-1.18 Million |
| 2018 | -30.36% | -60.98% | 0.43x | 1.17x | AU$-1.74 Million |
| 2019 | -40.98% | -57.48% | 0.55x | 1.29x | AU$-1.57 Million |
| 2020 | -23.20% | -26.25% | 0.68x | 1.30x | AU$-848.73K |
| 2021 | -26.35% | -23.49% | 0.79x | 1.42x | AU$-683.82K |
| 2022 | 0.00% | -106.55% | 1.04x | 0.00x | AU$-457.54K |
| 2023 | -12.82% | -37.59% | 0.29x | 1.17x | AU$-3.45 Million |
| 2024 | -369.50% | -142.90% | 1.39x | 1.86x | AU$-13.69 Million |
| 2025 | 41.95% | 16.11% | 1.46x | 1.79x | AU$3.73 Million |
Industry Comparison
This section compares Bioxyne Ltd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $70,620,960
- Average return on equity (ROE) among peers: -75.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bioxyne Ltd (BXN) | AU$20.17 Million | -11.47% | 0.72x | $20.44 Million |
| Australian Dairy Nutritionals Ltd (AHF) | $1.01 Million | 0.00% | 0.38x | $6.83 Million |
| Beston Global Food Company Ltd (BFC) | $117.17 Million | -1.19% | 0.09x | $3.27 Million |
| Biome Australia Ltd (BIO) | $3.59 Million | -85.84% | 1.11x | $31.40 Million |
| Cobram Estate Olives Ltd (CBO) | $141.21 Million | -0.58% | 0.92x | $642.39 Million |
| The Calmer Co International Ltd (CCO) | $104.56K | -4.18% | 0.06x | $2.07 Million |
| EVE Health Group Limited (EVE) | $2.64 Million | -278.66% | 0.05x | $1.87 Million |
| Forbidden Foods Ltd (FFF) | $1.77 Million | -313.05% | 0.49x | $1.49 Million |
| Fonterra Shareholders Fund (FSF) | $325.00 Million | 0.00% | 0.17x | $26.81K |
| Health and Plant Protein Group Ltd (HPP) | $43.09 Million | 0.67% | 0.99x | $448.86K |